About EndoGastric Solutions
EndoGastric Solutions is a Healthcare company based in San Mateo (United States) founded in 2002. Incisionless transoral procedures for upper GI diseases are developed. EndoGastric Solutions has raised $355.2 million across 18 funding rounds from investors including Canaan, Accelmed and Canepa Healthcare. The company has 80 employees. Its chief executive, as recorded, is Skip Baldino. EndoGastric Solutions offers products and services including EsophyX® Device, TIF 2.0®, and cTIF™. Its focus areas include Life Sciences, Gastroenterology, Medical Devices and Therapeutic Devices. Its legal entity is ENDOGASTRIC SOLUTIONS, INC. Its competitors include EndoChoice, CoapTech and SafeStitch; 3 of its 3 listed competitors have raised funding.
Company details
EndoGastric Solutions was founded in 2002 in San Mateo, United States, as a medical technology firm focused on the gastrointestinal sector. Devices such as EsophyX and Stomaphyx are designed and manufactured for endoluminal transoral applications, including tissue approximation, placation, and ligation. These tools address conditions like gastroesophageal reflux disease and other upper GI disorders through minimally invasive techniques. Operations center on innovation in natural orifice surgery methods.
- Headquarters San Mateo, United States
- Employees 80
- SectorsHealthcare
- Website endogastricsolutions.com
- Social LinkedIn X
- Legal Name Endogastric Solutions, Inc.
- Total Equity Funding$355.2M (USD)
in 18 rounds
- Latest Funding Round$27M (USD), Series J
Dec 2021
- InvestorsCanaan
& 11 more
- Employee Count80
Products & Services of EndoGastric Solutions
EndoGastric Solutions offers a comprehensive portfolio of products and services, including EsophyX® Device, TIF 2.0®, and cTIF™.
Treats GERD through transoral incisionless fundoplication procedure.
Restores stomach anatomy to prevent acid reflux in patients.
Offers standardized fundoplication for digestive disease management.
Funding Insights of EndoGastric Solutions
EndoGastric Solutions has successfully raised a total of $355.2M across 18 strategic funding rounds. The most recent funding activity was a Series J round of $27 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $355.2M
- Total Rounds 18
- Last Round Series J — $27M
- First Round $5M
(Jun 2003)
- Investors Count 12
Latest 10 of 18 funding rounds of EndoGastric Solutions with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2021 | $27M | Series J | – | – | – |
| May 2019 | $14.5M | Series I | – | Accelmed | – |
| Jul 2018 | $30.5M | Series I | – | Canaan, Canepa Healthcare | – |
| Jun 2018 | $25.47M | Series H | – | – | – |
| Dec 2015 | $50M | Series H | – | Advanced Technology Ventures, Chicago Growth Partners | – |
| May 2015 | $10.01M | Series H | – | – | – |
| Apr 2015 | $1.29M | Series G | – | – | – |
| May 2014 | $30.64M | Series G | – | Advanced Technology Ventures, Canaan | – |
| Apr 2014 | $1M | Debt – Conventional | – | – | – |
| Aug 2013 | $12.79M | Series G | – | – | – |
12 investors in total: 12 institutional.
Investors in EndoGastric Solutions
EndoGastric Solutions has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Canaan, Accelmed and Canepa Healthcare.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| accelmed.com | ||||
Canaan is recognized as an early-stage venture capital firm. | 1987 | canaan.com | San Francisco, United States | |
| canepahealthcare.com | ||||
PE firm investing in the US | cgp.com | Chicago, United States | ||
| radiusventures.com | ||||
Sightline Partners is focused on secondary buyouts and joint ventures in healthcare. | 2004 | sightlinepartners.com | Bloomington, United States | |
VC firm making investment in early stage startups in the US | atvcapital.com | Menlo Park, United States | ||
CRG is recognized as a premier healthcare investment partner. | crglp.com | Houston, United States | ||
| denovovc.com | ||||
Growth stage VC fund investing in the US, Europe and Canada | oakwoodmedical.com | St. Louis, United States |
Investor details for EndoGastric Solutions
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of EndoGastric Solutions
10 people are tracked at EndoGastric Solutions (2 in leadership, 5 in board & advisors, 3 in team); the tracked headcount is 80.
| Name | Role | Group |
|---|---|---|
Skip Baldino | CEO & President | Leadership |
Darren Crow | VP, R&D Operations | Leadership |
John Gillings | Director | Board & advisors |
Kunal Paymaster | Director | Board & advisors |
Brent Ahrens | Director | Board & advisors |
Alejandro Sanchez | Director | Board & advisors |
Michael Carusi | Director | Board & advisors |
Karen Gerth | Market Development Manager | Team |
Trent Compton | Sales Executive / Program Development Manager | Team |
Lisa Bryan | Clinical Sales Manager | Team |
Complete people profiles for EndoGastric Solutions
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of EndoGastric Solutions
3 dated milestones of EndoGastric Solutions across 19 years, from founding to its latest funding, stage changes and deals.
- Founded EndoGastric Solutions is founded.
- Funding First funding round of $5.0M.
- Funding Latest funding round, Series J, of $27.0M.
Competitors of EndoGastric Solutions
EndoGastric Solutions has 3 listed competitors in our database, 3 of them funded. They include EndoChoice, CoapTech and SafeStitch.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| endochoice.com | 2008 | Alpharetta, United States | $115.96M | 414 | Devices, systems, and services are provided for GI specialists. | |
| coaptech.com | 2016 | Baltimore, United States | $16.52M | Minimally invasive gastrostomy feeding tube placement method is developed. | ||
| safestitch.com | 2005 | Miami, United States | $7.58M | 167 | Medical devices for gastrointestinal and bariatric surgery are developed. |
Detailed competitors of EndoGastric Solutions
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of EndoGastric Solutions
The website of EndoGastric Solutions (endogastricsolutions.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▼ 58.4% vs previous month
Websites whose visitors overlap most with EndoGastric Solutions. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| phoebehealth.com | 100% | 36.5K | #763,554 | View details | |
realize.com | realize.com | 99% | #218,284 | – | |
lapband.com | lapband.com | 99% | #5,673,206 | – | |
georgiarefluxsurgery.com | georgiarefluxsurgery.com | 89% | – | ||
| toraxmedical.com | 89% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 11 similar websites and full traffic analytics for EndoGastric Solutions
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Gastroenterology
3 companies that operate in the same segment as EndoGastric Solutions (Gastroenterology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for gastrointestinal disorders, including linaclotide, are developed. | 1998 | Cambridge, Massachusetts, United States | USD 206.25 M | USD 296.15 M | 253 | |
Sacral neuromodulation devices are developed for urinary and bowel control. | 2013 | Irvine, California, United States | USD 143.47 M | |||
Provider of a deep learning platform for detecting circulating cancer-related markers | 2014 | United States | USD 1.35 B | 411 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Endogastric Solutions
Complete news archive for EndoGastric Solutions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EndoGastric Solutions
EndoGastric Solutions was founded in 2002 and raised its 1st funding round 1 year after it was founded.
EndoGastric Solutions is headquartered in San Mateo, United States. It is registered at San Mateo, California, United States.
Skip Baldino is the CEO of EndoGastric Solutions, as recorded in our data.
EndoGastric Solutions is a funded company, having raised a total of $355.2M across 18 funding rounds to date. The company's 1st funding round was a Series G of $12.79M, raised on Jun 2003.
EndoGastric Solutions has 80 employees.
EndoGastric Solutions was founded in 2002 in San Mateo, United States, as a medical technology firm focused on the gastrointestinal sector. Devices such as EsophyX and Stomaphyx are designed and manufactured for endoluminal transoral applications, including tissue approximation, placation, and ligation. These tools address conditions like gastroesophageal reflux disease and other upper GI disorders through minimally invasive techniques. Operations center on innovation in natural orifice surgery methods.
EndoGastric Solutions's top competitors include CoapTech, EndoChoice and SafeStitch.
EndoGastric Solutions offers EsophyX® Device, TIF 2.0®, and cTIF™.
EndoGastric Solutions has 12 investors. Key investors include Canaan, Accelmed, Canepa Healthcare, Chicago Growth Partners, and Radius Ventures.
EndoGastric Solutions operates through Endogastric Solutions, Inc..